{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:16:11Z","timestamp":1794564971699,"version":"4.9.1"},"reference-count":19,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Am J Mens Health"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>Prostate cancer is the second most common cancer in U.S. men, with higher incidence and mortality among African Americans and those with genetic or familial risk. Despite guidelines promoting early detection, prostate-specific antigen (PSA) screening in primary care remains inconsistent. We assessed PSA screening patterns and the association between risk factors and testing.<\/jats:p>\n                  <jats:p>\n                    A retrospective analysis was conducted on men aged \u226540 seen at primary care clinics from 2020 to 2022. Risk scores were created based on the number of prostate cancer risk factors. Univariate and multivariate analyses assessed associations between the risk scores, PSA screening, and cancer diagnosis. Of 176,326 patients, 31.4% underwent PSA testing, rising to 78.1% with a risk score of 4. The predictive model was significant (\u03c7\n                    <jats:sup>2<\/jats:sup>\n                    = 19,527.021,\n                    <jats:italic toggle=\"yes\">df<\/jats:italic>\n                    = 11,\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    &lt; .001). PSA testing odds were higher with Medicaid or commercial insurance (vs. Medicare) and lower for self-pay patients. Former and never smokers were more likely to be tested than current smokers. Age, African American race, and family history increased the odds of receiving PSA testing. Prostate cancer diagnosis reached 25% at a risk score of 5, with significant predictors including older age, African American race, family history, and mention of \u201cprostate\u201d in clinical notes. PSA screening remains underused in primary care, even among high-risk patients. More risk factors were linked to higher testing rates, but African American and low-income groups were under-tested. Provider education and decision-support tools may improve guideline adherence and equity.\n                  <\/jats:p>","DOI":"10.1177\/15579883251392440","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:51:38Z","timestamp":1763635898000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Prostate Cancer Screening Practices Among High-Risk Patients: A Retrospective Analysis"],"prefix":"10.1177","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9247-5999","authenticated-orcid":false,"given":"Aditya K.","family":"Ghosh","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barath P.","family":"Sivasubramanian","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Northeast Georgia Medical Center, Gainesville, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana H.","family":"Asif","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Northeast Georgia Medical Center, Gainesville, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Barker","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Northeast Georgia Medical Center, Gainesville, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Dirisanala","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Northeast Georgia Medical Center, Gainesville, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane S.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Graduate Medical Center\u2014Research &amp; Quality Improvement, Northeast Georgia Medical Center, Gainesville, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania Izabela","family":"Rynarzewska","sequence":"additional","affiliation":[{"name":"Department of Management, Marketing, and Logistics, Georgia College &amp; State University, Milledgeville, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology; Longstreet Clinic Cancer Center, Gainesville, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"Cancer Statistics Review 1975\u20132012\u2014Previous Version\u2014SEER Cancer Statistics Review. (n.d.). SEER. http:\/\/seer.cancer.gov\/archive\/csr\/1975_2012\/"},{"key":"e_1_3_3_3_1","doi-asserted-by":"crossref","unstructured":"Denijs F. B. Van Poppel H. Stenzl A. Villanueva T. Vilaseca J. M. Ungan M. Deschamps A. Collen S. Roobol M. J. (2024). PSA testing in primary care: Is it time to change our practice? BMC Primary Care 25(1) Article 436. https:\/\/doi.org\/10.1186\/s12875-024-02688-8","DOI":"10.1186\/s12875-024-02688-8"},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","unstructured":"Dess R. T. Hartman H. E. Mahal B. A. Soni P. D. Jackson W. C. Cooperberg M. R. Amling C. L. Aronson W. J. Kane C. J. Terris M. K. Zumsteg Z. S. Butler S. Osborne J. R. Morgan T. M. Mehra R. Salami S. S. Kishan A. U. Wang C. Schaeffer E. M. .\u2004.\u2004.Spratt D. E. (2019). Association of black race with prostate cancer-specific and other-cause mortality. JAMA Oncology 5(7) 975\u2013983. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0826","DOI":"10.1001\/jamaoncol.2019.0826"},{"key":"e_1_3_3_5_1","unstructured":"Early Detection of Prostate Cancer: AUA\/SUO Guideline (2023)\u2014American Urological Association. (n.d.). https:\/\/www.auanet.org\/guidelines-and-quality\/guidelines\/early-detection-of-prostate-cancer-guidelines"},{"key":"e_1_3_3_6_1","doi-asserted-by":"crossref","unstructured":"Estevan-Ortega M. de la Encarnaci\u00f3n Castellano C. Mendiola-L\u00f3pez A. Parker L. A. Caballero-Romeu J. P. Lumbreras B. (2024). Urologists\u2019 and general practitioners\u2019 knowledge beliefs and practice relevant for opportunistic prostate cancer screening: A PRISMA-compliant systematic review. Frontiers in Medicine 11 Article 1283654. https:\/\/doi.org\/10.3389\/fmed.2024.1283654","DOI":"10.3389\/fmed.2024.1283654"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","unstructured":"Garraway I. P. Carlsson S. V. Nyame Y. A. Vassy J. L. Chilov M. Fleming M. Frencher S. K. George D. J. Kibel A. S. King S. A. Kittles R. Mahal B. A. Pettaway C. A. Rebbeck T. Rose B. Vince R. Winn R. A. Yamoah K. Oh W. K. (2024). Prostate cancer foundation screening guidelines for Black men in the United States. NEJM Evidence 3(5) EVIDoa2300289. https:\/\/doi.org\/10.1056\/EVIDoa2300289","DOI":"10.1056\/EVIDoa2300289"},{"key":"e_1_3_3_8_1","unstructured":"Guidelines Detail. (n.d.). NCCN. Retrieved February 21 https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1459"},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","unstructured":"Harmatz I. M. Alkhatib K. Y. Leff M. Nolazco J. I. Michel K. F. Slinger M. McLauchlan N. Cortese B. D. Roberson D. S. Schurhamer B. Lee D. J. Malkowicz S. B. Trinh Q.-D. Bivalacqua T. J. Guzzo T. J. Pierorazio P. M. (2024). Prostate-specific antigen screening in smokers: A comprehensive analysis using a national behavioral survey. Urology Practice 11(3) 547\u2013556. https:\/\/doi.org\/10.1097\/UPJ.0000000000000553","DOI":"10.1097\/UPJ.0000000000000553"},{"key":"e_1_3_3_10_1","doi-asserted-by":"crossref","unstructured":"Hinata N. Fujisawa M. (2022). Racial differences in prostate cancer characteristics and cancer-specific mortality: An overview. The World Journal of Men\u2019s Health 40(2) 217\u2013227. https:\/\/doi.org\/10.5534\/wjmh.210070","DOI":"10.5534\/wjmh.210070"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","unstructured":"Iyer H. S. Kensler K. H. Roscoe C. Opara C. He M. Kovac E. Garraway I. P. Dien-Trinh Q. Rebbeck T. R. (2024). Multidimensional healthcare access barriers to prostate-specific antigen testing: A nation-wide panel study in the United States from 2006 to 2020. Cancer Medicine 13(21) Article e70358. https:\/\/doi.org\/10.1002\/cam4.70358","DOI":"10.1002\/cam4.70358"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","unstructured":"Lucas M. I. Qian Z. Lipsitz S. R. Chen X. Alkhatib K. Kibel A. S. Cole A. P. Iyer H. S. Trinh Q.-D. (2024). Long-term impact of Medicaid expansion on prostate cancer screening. Urology Practice 11(1) 78\u201384. https:\/\/doi.org\/10.1097\/UPJ.0000000000000464","DOI":"10.1097\/UPJ.0000000000000464"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","unstructured":"Merrill R. M. Gibbons I. S. (2024). Prostate-specific antigen testing in the United States during 2008-2022 in relation to the US preventive services task force recommendations. Scientific Reports 14(1) 31345. https:\/\/doi.org\/10.1038\/s41598-024-82821-w","DOI":"10.1038\/s41598-024-82821-w"},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","unstructured":"Morgan O. Schnur J. B. Diefenbach M. A. Kale M. S. (2024). Physician preferences for an electronic lung cancer screening decision aid. The American Journal of Managed Care 30(6 Spec) SP445\u2013SP451. https:\/\/doi.org\/10.37765\/ajmc.2024.89551","DOI":"10.37765\/ajmc.2024.89551"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","unstructured":"Nguyen A. Fastenau J. Mehta J. Kovac E. Weiss R. E. (2024). National trends in PSA cancer screening with parallel investigation of colorectal cancer screening: An analysis of the CDC behavioral risk factor surveillance system from 2012 to 2022. Clinical Genitourinary Cancer 22(6) 102178. https:\/\/doi.org\/10.1016\/j.clgc.2024.102178","DOI":"10.1016\/j.clgc.2024.102178"},{"key":"e_1_3_3_16_1","unstructured":"Sajadi Kaboudi P. Halakoo M. Ezoji K. Shafee H. Hosseini S. R. Bijani A. (2024). Serum vitamin D and PSA in elderly men in Amirkola. Caspian Journal of Internal Medicine 15(3) 535\u2013541. https:\/\/doi.org\/10.22088\/cjim.15.3.535"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","unstructured":"Tidd-Johnson A. Sebastian S. A. Co E. L. Afaq M. Kochhar H. Sheikh M. Mago A. Poudel S. Fernandez J. A. Rodriguez I. D. Razdan S. (2022). Prostate cancer screening: Continued controversies and novel biomarker advancements. Current Urology 16(4) 197\u2013206. https:\/\/doi.org\/10.1097\/CU9.0000000000000145","DOI":"10.1097\/CU9.0000000000000145"},{"key":"e_1_3_3_18_1","unstructured":"USCS Data Visualizations. (n.d.). https:\/\/gis.cdc.gov\/Cancer\/USCS\/#\/Demographics\/"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","unstructured":"US Preventive Services Task Force Grossman D. C. Curry S. J. Owens D. K. Bibbins-Domingo K. Caughey A. B. Davidson K. W. Doubeni C. A. Ebell M. Epling J. W.Jr Kemper A. R. Krist A. H. Kubik M. Landefeld C. S. Mangione C. M. Silverstein M. Simon M. A. Siu A. L. Tseng C.-W. (2018). Screening for prostate cancer: US Preventive Services Task Force recommendation statement. JAMA: The Journal of the American Medical Association 319(18) 1901\u20131913. https:\/\/doi.org\/10.1001\/jama.2018.3710","DOI":"10.1001\/jama.2018.3710"},{"key":"e_1_3_3_20_1","unstructured":"ZERO Prostate Cancer Connects People to Lifesaving Support. (n.d.). https:\/\/zerocancer.org\/"}],"container-title":["American Journal of Men's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15579883251392440","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15579883251392440","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15579883251392440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:28:20Z","timestamp":1777505300000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15579883251392440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1177\/15579883251392440"],"URL":"https:\/\/doi.org\/10.1177\/15579883251392440","relation":{},"ISSN":["1557-9883","1557-9891"],"issn-type":[{"value":"1557-9883","type":"print"},{"value":"1557-9891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"article-number":"15579883251392440"}}